Gynodian-depot
Gynodian-depot has been studied in 1 paper since 1981: 1 trial in people. The newest paper, Dec 1, 1981: “Catabolic effects and the influence on hormonal variables under treatment with Gynodian-Depot or dehydroepiandrosterone (DHEA) oenanthate”.
See all 1 papers on gynodian-depot
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
“Post-menopausally increased FSH and LH fractions were markedly suppressed in about half of the determinations after Gynodian-Depot administration”
Humans: a single group. Cells, worms or flies and mice: nothing yet.
- 1 lab in 1 country
- Human trial1
Studies in people
1 study gave gynodian-depot to people and measured what changed.
| What changed | Design | People | Source |
|---|---|---|---|
down: Decreases FSH and LHSuppression in about half of determinations | Trial | 53 peopleWomenpostmenopausalPostmenopausal women; Patient cohorts | Maturitas, Dec 1, 1981 |
What did studies of gynodian-depot find?
1Studies of gynodian-depot measured one outcome, FSH and LH.
FSH and LH
downin humans1
1 study
FSH and LH
downin humans1
Gynodian-depot decreases FSH and LH in humans (Suppression in about half of determinations).
“Post-menopausally increased FSH and LH fractions were markedly suppressed in about half of the determinations after Gynodian-Depot administration”
Human trial1 ampoule monthlyfemales
Maturitas
Latest
Maturitas
Catabolic effects and the influence on hormonal variables under treatment with Gynodian-Depot or dehydroepiandrosterone (DHEA) oenanthate
Non-randomized trial in 53 peopleInterventions